arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Thursday 1 July 2021

Thursday 01 Jul

08:30

Opening - by Presidents of EHNS, ESMO and ESTRO

Wojciech Golusiński, Poland Presidential Lecture

08:40

Surgical Innovation: Essential for Optimal Multidisciplinary Care of Oropharyngeal Cancer

Chris Holsinger, USA

09:00

Best Presentation from Young Scientist’s Forum

SESSION 1: FUTURE OF SURGICAL TREATMENTS.

Moderator: René Leemans, The Netherlands & Chair: Jan Klozar, Czech Republic

09:15

Is there a role of TORS in management of p16+ unknown primary cancer of the H&N?

Vinidh Paleri, United Kingdom

09:35

3D robotic like surgery

Giovanni Succo, Italy

09:55

Novel techniques for endoscopic skull base surgery

Antoine Moya-Plana, France

10:15

Image guided surgery

Max Witjes, The Netherlands

10:35

Coffee Break

SESSION 2: DEVELOPMENTS IN GENETICS AND DIAGNOSIS

Moderator: Pierre Saintigny

11:05

Intratumor genetic heterogeneity: current status and clinical relevance.

11:25

Liquid biopsy analysis in H&N cancer

Ingeborg Tinhofer-Keilholz, Germany

11:50

Proferred papers related to sessions 1-2

Moderator: Ahmet O. IKIZ, Turkey

12:40

Lunch break & visit virtual sponsor booth

12:45

Satellite symposium

SESSION III: RECURRENT HEAD AND NECK CANCER

Salvage treatments in recurrent head and neck cancer

14:00

Salvage surgery for locally recurrent head and neck cancer

Miguel Quer, Spain

14:20

Locoregional reirradiation for recurrent head and neck cancer in the IMRT and SBRT era.

14:40

Systemic therapy as monotherapy and in combination in head and neck cancer

Jan Vermorken, Belgium

PANEL: Salvage treatments in recurrent head and neck cancer: interactive case discussions

Moderators: Valentino Valentini, Italy

15:00

Panelists: Case discussion (voting)

Radiotherapy: Kenneth Jensen, Denmark & Oncology: Amanda Psyrri, Greece, Surgery: Gilles Dolivet, France; Surgery: Gregorio Sanchez Aniceto, Spain

15:40

Coffee Break

16:15

Proferred papers session 3

Chair: Antti Mäkitie

16:45

Concluding remarks session III

New data from randomised trials

Chair: Ana Castro & Moderator: Andreas Dietz

17:00

Introduction by the chair

17:05

Trial 1: A DAHANCA-EORTC blind randomised multicentric study of concomitant chemo-radiotherapy with or without the hypoxic cell sensitiser Nimorazole for locally advanced p16-negative head and neck SCC.

Vincent Grégoire, Belgium

17:20

Trail 2 Dependent from submssions

17:35

Trial 3 Dependent from submssions

SESSION 4: SALIVARY GLAND TUMORS

Moderator: Gerhard Hüber & Marc Hamoir

17:50

Keynote lecture: Histology-driven surgery in parotid carcinoma: fact or fiction?

Vincent Vanderpoorten, Belgium

18:10

Panelists: Case discussion (voting)

Surgery: Sefik Hosal, Turkey & Radiotherapy: Jean Bourhis, Switzerland & Oncology: Laura Locati, Italy

18:45

Satellite Symposium